# Safety and Efficacy of the Accent Magnetic Resonance Imaging™ (MRI) Pacemaker and Tendril MRI™ Lead

Study · id `cardio:ct-nct01576016` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01576016](<https://clinicaltrials.gov/study/NCT01576016>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01576016

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 950 participants.

## Technical summary

Registry record NCT01576016. Non-randomized; no masking; primary purpose treatment. Start 2012-03-30 (actual); primary completion 2018-02-02 (actual). Results posted on 2020-11-10.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 950 participants (enrolled count; ClinicalTrials.gov record NCT01576016, source copy `cardio:ctgov-nct01576016-2020-11-10`, retrieved 2026-10-26)
- Started: 2012-03-30 (actual) (ClinicalTrials.gov record NCT01576016, source copy `cardio:ctgov-nct01576016-2020-11-10`, retrieved 2026-10-26)
- Primary completion: 2018-02-02 (actual) (ClinicalTrials.gov record NCT01576016, source copy `cardio:ctgov-nct01576016-2020-11-10`, retrieved 2026-10-26)
- Completion: 2018-02-02 (actual) (ClinicalTrials.gov record NCT01576016, source copy `cardio:ctgov-nct01576016-2020-11-10`, retrieved 2026-10-26)
- Results first posted: 2020-11-10 (ClinicalTrials.gov record NCT01576016, source copy `cardio:ctgov-nct01576016-2020-11-10`, retrieved 2026-10-26)
- Countries: United States; Australia; Belgium; Finland; Netherlands (ClinicalTrials.gov record NCT01576016, source copy `cardio:ctgov-nct01576016-2020-11-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01576016-2020-11-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Efficacy of the Accent Magnetic Resonance Imaging™ (MRI) Pacemaker and Tendril MRI™ Lead
- Condition: Adverse Effect of MRI on an Implanted Pacemaker Lead
- Condition: Adverse Effect of MRI on an Implanted Pacemaker
- Intervention (Device): Accent MRI system (lead safety)
- Intervention (Device): Accent MRI system (with MRI scan)
- Lead sponsor: Abbott Medical Devices
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry lists this organization as the lead sponsor: Abbott (`cardio:abbott`)

## Provenance

Content hash: 46828953cc89224875ef5b077dca955d3c4bfd62914ab392e5d468b9ee8196a4
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
